Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Laura Faron-Yowe"'
Autor:
Jeffrey A. Ecsedy, Mark Manfredi, Katherine Galvin, Karthik Venkatakrishnan, Ole Petter Veiby, Stephen Tirrell, Bradley Stringer, Chris Simpson, Lee Silverman, Jodi Pappas, Hua Liu, Gary Gray, Laura Faron-Yowe, Hadi Danaee, Mengkun Zhang, Douglas Bowman, Bert ONeil, Corey J. Langer, Neal J. Meropol, Margaret von Mehren, Susana Rosello, Edith Rodriguez-Braun, Jordi Andreu, Elena Elez, Teresa Macarulla, Jeffrey R. Infante, Howard Burris, E. Claire Dees, Roger B. Cohen, Andres Cervantes, Josep Tabernero, Vaishali Shinde, Arijit Chakravarty
Supplementary Figure 2 from Phase I Assessment of New Mechanism-Based Pharmacodynamic Biomarkers for MLN8054, a Small-Molecule Inhibitor of Aurora A Kinase
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b55d8e6b42b33e9017f32e7cc7c8ab6
https://doi.org/10.1158/0008-5472.22386059
https://doi.org/10.1158/0008-5472.22386059
Autor:
Jeffrey A. Ecsedy, Mark Manfredi, Katherine Galvin, Karthik Venkatakrishnan, Ole Petter Veiby, Stephen Tirrell, Bradley Stringer, Chris Simpson, Lee Silverman, Jodi Pappas, Hua Liu, Gary Gray, Laura Faron-Yowe, Hadi Danaee, Mengkun Zhang, Douglas Bowman, Bert ONeil, Corey J. Langer, Neal J. Meropol, Margaret von Mehren, Susana Rosello, Edith Rodriguez-Braun, Jordi Andreu, Elena Elez, Teresa Macarulla, Jeffrey R. Infante, Howard Burris, E. Claire Dees, Roger B. Cohen, Andres Cervantes, Josep Tabernero, Vaishali Shinde, Arijit Chakravarty
Supplementary Tables 1-5 from Phase I Assessment of New Mechanism-Based Pharmacodynamic Biomarkers for MLN8054, a Small-Molecule Inhibitor of Aurora A Kinase
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30bf0bdc7eb5070d39976f349ddec62a
https://doi.org/10.1158/0008-5472.22386053
https://doi.org/10.1158/0008-5472.22386053
Autor:
Jeffrey A. Ecsedy, Mark Manfredi, Katherine Galvin, Karthik Venkatakrishnan, Ole Petter Veiby, Stephen Tirrell, Bradley Stringer, Chris Simpson, Lee Silverman, Jodi Pappas, Hua Liu, Gary Gray, Laura Faron-Yowe, Hadi Danaee, Mengkun Zhang, Douglas Bowman, Bert ONeil, Corey J. Langer, Neal J. Meropol, Margaret von Mehren, Susana Rosello, Edith Rodriguez-Braun, Jordi Andreu, Elena Elez, Teresa Macarulla, Jeffrey R. Infante, Howard Burris, E. Claire Dees, Roger B. Cohen, Andres Cervantes, Josep Tabernero, Vaishali Shinde, Arijit Chakravarty
Supplementary Figure 1 from Phase I Assessment of New Mechanism-Based Pharmacodynamic Biomarkers for MLN8054, a Small-Molecule Inhibitor of Aurora A Kinase
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36fb645294eaafd15f1dfcbd9e8cf7a1
https://doi.org/10.1158/0008-5472.22386062
https://doi.org/10.1158/0008-5472.22386062
Autor:
Jill Donelan, David I. Lichter, Paul Hales, Erik Koenig, Kristen Bano, Laura Faron-Yowe, Bradley Stringer, Hadi Danaee, Bret Bannerman, Kristin E. Burke, Trisha Babcock, Erik Kupperman
Publikováno v:
Blood. 114:3724-3724
Abstract 3724 Poster Board III-660 Lymphomas account for about 5% of all cases of cancer in the US. In 2009, it is estimated that 74490 Americans will be diagnosed with lymphoma, which includes approximately 8510 new cases of Hodgkin's lymphoma and 6